(1992) „Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo”. Blood80 (8), 1965–71. o. DOI:10.1182/blood.V80.8.1965.1965. PMID 1327286.
(2005) „Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis”. Cancer Cell7 (4), 387–97. o. DOI:10.1016/j.ccr.2005.03.023. PMID 15837627.
(1979) „Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement”. Acta Derm Venereol59 (6), 505–12. o. PMID 94209.
Berlin NI (1975). „Diagnosis and classification of polycythemias”. Semin Hematol12 (4), 339–351. o. PMID 1198126.
(1992) „Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo”. Blood80 (8), 1965–71. o. DOI:10.1182/blood.V80.8.1965.1965. PMID 1327286.
(2005) „Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis”. Cancer Cell7 (4), 387–97. o. DOI:10.1016/j.ccr.2005.03.023. PMID 15837627.